L-carnosine inhibits metastasis of SK-Hep-1 cells by inhibition of matrix metaoproteinase-9 expression and induction of an antimetastatic gene, nm23-H1

Nutrition and Cancer

Volumn 60, Issue 4, 2008, Pages 526-533

  Chuang, Cheng Hung ^a   Hu, Miao Lin ^b  

^a HUNGKUANG UNIVERSITY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARNOSINE; GELATINASE B; MESSENGER RNA; NUCLEOSIDE DIPHOSPHATE KINASE A;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL FREE SYSTEM; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; IC 50; LIVER CELL CARCINOMA; METASTASIS; METASTASIS INHIBITION; PROTEIN EXPRESSION;

CARCINOMA, HEPATOCELLULAR; CARNOSINE; CELL LINE, TUMOR; CELL MOVEMENT; ENZYME INHIBITORS; GENE EXPRESSION; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; RNA, MESSENGER;

EID: 46349084784     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580801911787     Document Type: Article

References (48)

1. Fidler IJ and Kripke ML: Metastasis results from preexisting variant cells within a malignant tumor. Science 197, 893-895, 1977.
2. Sternlicht MD and Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17, 465-516, 2001.
3. Birkedal-Hansen H: Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7, 728-735, 1995.
4. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, et al.: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 84, 67-68, 1980.
5. Chandler S, Miller KM, Clements JM, Lury J, Corkill D, et al.: Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J Neuroimmunol 72, 155-161, 1997.
6. Liabakk NB, Talbot I, Smith RA, Wilkinson K, and Balkwill F: Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 56, 190-196, 1996.
7. Hidalgo M and Eckhardt SG: Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 93, 178-193, 2001.
8. Zhang M, Altuwaijri S, and Yeh S: RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness. Oncogene 23, 3080-3088, 2004.
9. Nagase H: Activation mechanisms of matrix metalloproteinases. Biol Chem 378, 151-160, 1997.
10. Richard D, Hollender P, and Chenais B: Butyric acid increases invasiveness of HL-60 leukemia cells: role of reactive oxygen species. FEBS Lett 518, 159-163, 2002.
11. Yoo HG, Shin BA, Park JS, Lee KH, Chay KO, et al.: IL-1beta induces MMP-9 via reactive oxygen species and NF-kappaB in murine macrophage RAW 264.7 cells. Biochem Biophys Res Commun 298, 251-256, 2002.
12. Kim MS, Kang HJ, and Moon A: Inhibition of invasion and induction of apoptosis by curcumin in H-ras-transformed MCF10A human breast epithelial cells. Arch Pharm Res 24, 349-354, 2001.
13. Orbe J, Rodriguez JA, Arias R, Belzunce M, Nespereira B, et al.: Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: implications for plaque stabilization. Atherosclerosis 167, 45-53, 2003.
14. Aggarwal BB, Kumar A, and Bharti AC: Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23, 363-398, 2003.
15. Maeda K, Kuzuya M, Cheng XW, Asai T, Kanda S, et al.: Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier. Atherosclerosis 166, 23-30, 2003.
16. Lappas M, Permezel M, and Rice GE: N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-κ B deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab 88, 1723-1729, 2003.
17. Huang CS, Shih MK, Chuang CH, and Hu ML: Lycopene inhibits cell migration, invasion and uprgulates nm23-H1 in a highly invasive hepatocarcinogma, SK-Hep-1 cells. J Nutr 135, 2119-2123, 2005.
18. Lim S, Lee HY, and Lee H: Inhibition of colonization and cell-matrix adhesion after nm23-H1 transfection of human prostate carcinoma cells. Cancer Lett 133, 143-149, 1998.
19. Tannapfel A, Kockerling F, Katalinic A, and Wittekind C: Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma. Dis Colon Rectum 38, 651-654, 1995.
20. Viel A, Dall AL, Canzonieri V, Sopracordevole F, Capozzi E, et al.: Suppressive role of the metastasis-related nm23-H1 gene in human ovarian node metastasis. Cancer Res 55, 2645-2650, 1995.
21. Nakayama T, Ohtsuru A, Nakao K, Shima M, Nakata K, et al.: Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product. J Natl Cancer Inst 84, 1349-1354, 1992.
22. Kuppers DA, Lan K, Knight JS, and Robertson ES: Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and suppressor of metastasis nm23-H1. J Virol 79, 9714-9724, 2005.
23. Curtis CD, Likhite VS, McLeod IX, Yates JR, and Nardulli AM: Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor alpha alters estrogen-responsive gene expression. Cancer Res 67, 10600-10607, 2007.
24. Hartsough MT, Clare SE, Mair M, Elkahloun AG, Sgroi D, et al.: Elevation of breast carcinoma nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition. Cancer Res 61, 2320-2327, 2001.
25. Zhao H, Jhanwar-Uniyal M, Datta PK, Yemul S, Ho L, et al.: Expression profile of gene associated antimetastatic gene: nm23-mediated metastasis inhibition in breast carcinoma cells. Int J Cancer 109, 65-70, 2004.
26. Liu F, Qi HL, and Chen HL: Effects of all-trans retinoic acid and epidermal growth factor on the expression of nm23-H1 in human hepatocarcinoma cells. J Cancer Res Clin Oncol 126, 85-90, 2000.
27. Liu F, Zhang Y, Zhang XY, and Chen HL: Transfection of the nm23-H1 gene into human hepatocarcinoma cell lines inhibits the expression of sialyl Lewis X, α1,3 fucosyltransferase VII, and metastatic potential. J Cancer Res Clin Oncol 128, 189-196, 2002.
28. Cheng S, Alfonso-Jaume MA, Mertens PR, and Lovett DH: Tumour metastasis suppressor, nm23-beta, inhibits gelatinase A transcription by interference with transactivator Y-box protein-1 (YB-1). Biochem J 366, 807-816, 2002.
29. Decker EA, Crum AD, and Calvert JT: Differences in the antioxidant mechanism of carnosine in the presence of copper and iron. J Agric Food Chem 40, 756-759, 1992.
30. Quinn PJ, Boldyrev AA, and Formazuyk VE: Carnosine: its properties, function and potential therapeutic applications. Mol Aspects Med 13, 379-444, 1992.
31. Hipkiss AR, Michaelis J, and Syrris P: Non-enzymic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross-linking agent. FEBS Lett 371, 81-85, 1995.
32. Harris RC, Marlin DJ, Dunnett M, Snow DH, and Hultman E: Muscle buffering capacity and dipeptide content in the thoroughbred horse, greyhound dog and man. Comp Biochem Physiol A 97, 249-251, 1990.
33. Ohba K, Miyata Y, Koga S, Kanda S, and Kanetake H: Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2. Urology 65, 1029-1234, 2005.
34. Phillips JJ: Dye exclusion tests for cell viability. In: Tissue Cultures: Methods and Applications, Kruse PF and Patterson MK (eds.). New York: Academic Press, 1973, pp. 406-408.
35. Aruoma OI, Laughton MJ, and Halliwell B: Carnosine, homocarnosine and anserine: could they act as antioxidants in vivo? Biochem J 264, 863-869, 1989.
36. Repesh LA: A new in vitro assay for quantitating tumor cell invasion. Invasion Metast 9, 192-208, 1989.
37. Hwang HJ, Park HJ, Chung HJ, Min HY, Park EJ, et al.: Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells. J Nutr Biochem 17, 356-362, 2006.
38. Lin LI, Ke YF, Ko YC, and Lin JK: Curcumin inhibits SK-Hep-1 heaptocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion. Oncology 55, 349-353, 1998.
39. Hwang ES and Lee HJ: Inhibitory effects of lycopene on the adhesion, invasion, and migration of SK-Hep-1 Human Hepatoma cells. Exp Biol Med 231, 322-327, 2006.
40. Hozumi A, Nishimura Y, Nishiuma T, Kotani Y, and Yokoyama M: Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway. Am J Physiol Lung Cell Mol Physiol 281, 1444-1452, 2001.
41. Yoshikawa T, Naito Y, Tanigawa T, Yoneta T, and Kondo M: The antioxidant properties of a novel zinc-carnosine chelate compound, N-(3-aminopropionyl)-L- histidine to zinc. Biochim Biophys Acta 1115, 15-22, 1991.
42. Khan MH, Yasuda M, Higashino F, Haque S, Kohgo T, et al.: nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression. Am J Pathol 158, 1785-1791, 2001.
43. Boone TC, Johnson MJ, De Y, Clerck A, and Langley KE: cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. Proc Natl Acad Sci USA 87, 2800-2804, 1990.
44. Greene J, Wang M, Liu YE, Raymond LA, Rosen C, et al.: Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 271, 30375-30380, 1996.
45. Begum G, Cunliffe A, and Leveritt M: Physiological role of carnosine in contracting muscle. Int J Sport Nutr Exerc Metab 15, 493-514, 2005.
46. Park YJ, Volpe SL, and Decker EA: Quantitation of carnosine in human plasma after dietary consumption of beef. J Agric Food Chem 53, 4736-4639, 2005.
47. Jackson MC and Lenney JF: The distribution of carnosine and related dipeptides in rat and human tissues. Inflamm Res 45, 132-135, 1996.
48. Crush KG: Carnosine and related substances in animal tissues. Comp Biochem Physiol 34, 3-30, 1970.